Byetta

Byetta is an in injectable drug (exenatide) for the treatment of type 2 diabetes which is marketed by Amylin Pharmaceuticals and Eli Lilly. The drug was approved for use by the U.S. Food and Drug Administration for use in April 2005. 

Company Website
Website: http://www.byetta.com/index.jsp

Other SourceWatch Resources

 * Delta Burke
 * Drug industry